← FDA Drug Approvals (Drugs@FDA)

ULTACAN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HANSAMED INC · Approved 2017-07-11

Drug application

FDA Application #

ANDA201751

Application type

Abbreviated New Drug Application (Generic)

Brand name

ULTACAN

Generic name

Articaine Hydrochloride

Active ingredients

ARTICAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Discontinued

Sponsor

HANSAMED INC

First approval

2017-07-11

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown